MondegarAI
Parsifal Capital Management, LP

Q4 2025 · 13F-HR

Parsifal Capital Management, LPholdings as filed

Filed 2026-02-17 · accession 0001776090-26-000002

$1.22B
Reported value
18
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · Parsifal Capital Management, LP · Q4 2025

AI · grounded in 13F

Parsifal Capital Management, LP exited its position in DLTR, reducing exposure by $99.3M. The fund established new positions in COMP for $106.9M, WBD for $96.7M, and AXTA for $70.6M. Additionally, the manager increased its holdings in TEVA by 40.26% and GMED by 10.72%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G8068L108SNSHARKNINJA INC$134.3M11.0%1,199,937CommonSOLE
43283X105HGVHILTON GRAND VACATIONS INC$110.8M9.09%2,475,501CommonSOLE
20464U100COMPCOMPASS INC$106.9M8.76%10,110,100CALLSOLE
379577208GMEDGLOBUS MED INC$106.8M8.76%1,222,717CommonSOLE
934423104WBDWARNER BROS DISCOVERY INC$96.7M7.93%3,356,800CALLSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$88.0M7.22%2,819,933CommonSOLE
36262G101GXOGXO LOGISTICS INCORPORATED$75.9M6.22%1,441,613CommonSOLE
G0750C108AXTAAXALTA COATING SYS LTD$70.6M5.79%2,184,355CommonSOLE
88579Y101MMM3M CO$66.8M5.48%417,358CommonSOLE
04956D107ATMUATMUS FILTRATION TECHNOLOGIE$64.1M5.26%1,234,287CommonSOLE
925550105VIAVVIAVI SOLUTIONS INC$60.3M4.95%3,385,700CommonSOLE
053604104AVPTAVEPOINT INC$52.1M4.27%3,752,179CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$49.6M4.07%150,258CommonSOLE
013091103ACIALBERTSONS COS INC$42.4M3.48%2,469,593CommonSOLE
44951W106IESCIES HLDGS INC$39.0M3.20%100,180CommonSOLE
98954M200ZZILLOW GROUP INC$23.0M1.89%337,800PUTSOLE
21874A106CORZCORE SCIENTIFIC INC NEW$17.4M1.43%1,197,600CommonSOLE
546347105LPXLOUISIANA PAC CORP$14.6M1.19%180,168CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.